| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/17/2009 | EP2029177A4 Method and system for preparing soft tissue for grafting, enhancing grafting results, and grafting autologous fat and adipocyte derived stem cells to soft tissue such as the breast and other tissue defects |
| 06/17/2009 | EP1602669B1 Antibody against a tumor-specific antigen as target |
| 06/17/2009 | EP1147205B1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 06/17/2009 | EP0968277B1 Filtration method for separating viruses |
| 06/17/2009 | CN101455846A Tuberculosis gene vaccine assembled by chitosan delivery system and preparation method and use thereof |
| 06/17/2009 | CN100500222C Cancer targeted double gene-virus, its structure method and application thereof |
| 06/17/2009 | CN100500210C Use of il-18 inhibitors in hypersensitivity disorders |
| 06/16/2009 | US7547816 Genetically engineered, galactosyltransferase deficient, pigs for use as source of organs, tissues and cells for xenotransplantation |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547683 Nucleic acid injected into hepatic vein lumen |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547681 Surface receptor antigen vaccines |
| 06/16/2009 | US7547521 Heteromultimeric ion channel receptor and uses thereof |
| 06/16/2009 | US7547513 Mutants of deoxycytidine kinase having extended enzymatic activity |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2326327C Recombinant adeno-associated virus vector encoding alpha-1-antitrypsin serum protein |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/11/2009 | WO2009073104A2 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 06/11/2009 | WO2009073103A2 Simian subfamily b adenoviruses sadv-28,27,-29,-32,-33, and -35 and uses thereof |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009054996A3 Systems and methods for viral therapy |
| 06/11/2009 | WO2009053937A3 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 06/11/2009 | WO2009044165A3 Molecular adjuvant |
| 06/11/2009 | WO2009027978A8 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS |
| 06/11/2009 | WO2007021896A3 Chemically modified oligonucleotides for use in modulating micro rna and uses thereof |
| 06/11/2009 | WO2003024312A3 Cell therapy system |
| 06/11/2009 | WO2003021227A3 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002089727A3 Methods of using cytokine c17 |
| 06/11/2009 | WO2002089658A3 Microvascular free flaps for local or systemic delivery |
| 06/11/2009 | WO2002048314A3 Antisense modulation of raidd expression |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090149644 siRNA Targeting KRAS |
| 06/11/2009 | US20090149642 Enriched preparation of human fetal multipotential neural stem cells |
| 06/11/2009 | US20090149409 Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System |
| 06/11/2009 | US20090149406 Plasmid PXL3179 or NV1FGF |
| 06/11/2009 | US20090149404 Oligonucleotide analogues and methods utilizing the same |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090149377 METHODS FOR REGULATION OF p53 TRANSLATION AND FUNCTION |
| 06/11/2009 | US20090149373 Use of survivin to treat kidney failure |
| 06/11/2009 | US20090149339 Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090148936 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148508 Methods of compositions for the treatment of ocular diseases |
| 06/11/2009 | US20090148478 Combinations of tumor-associated antigens in compositions for various types of cancers |
| 06/11/2009 | US20090148452 Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| 06/11/2009 | US20090148439 by use of a polypeptide (CD27L); in particular kidney cancer; monitoring the effectiveness of epithelial-derived cancer therapy |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2706258A1 Simian subfamily e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38 and uses thereof |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2066795A2 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 06/10/2009 | EP2066791A2 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders |
| 06/10/2009 | EP2066356A2 Novel p. falciparum vaccine proteins and coding sequences |
| 06/10/2009 | EP1685254B1 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/10/2009 | EP1579870B1 Vaccines comprising polynucleotides |
| 06/10/2009 | EP1487499B1 Contrast agents for magnetic resonance imaging and methods related thereto |
| 06/10/2009 | CN101454451A C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 06/10/2009 | CN101450216A Medicine for preventing hyperplastic scar fibroblast proliferation |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497610C Polypeptides encoded by human lipase-like gene and composition, and methods of utilizing same |
| 06/10/2009 | CN100497605C Anti cancer targeted regulatory gene-virus and construction method thereof |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100496614C Small interference RNA molecule for restraining protein expression of DNA-PKCS, and encoding gene and application |
| 06/09/2009 | US7544855 Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664 |
| 06/09/2009 | US7544791 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544777 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544664 Sequences facilitating penetration of a substance of interest |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544492 Polynucleotide sequences coding human weight regulatory protein; therapy and diagnostic tool for eating disorders, cachexia; gene therapy; modulators of body weight |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544474 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals; using chemiluminescence labels acridinium dye; diagnosing diseases by detect nucleic acid has been used for diseases associated with abnormal gene products |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
| 06/04/2009 | WO2009070805A2 Mir-124 regulated genes and pathways as targets for therapeutic intervention |
| 06/04/2009 | WO2009070328A1 Modulators of the epidermal growth factor receptor (egfr) pathway for use in the treatment or prevention of substance abuse |
| 06/04/2009 | WO2009070244A2 Methods for inhibiting fascin |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009068870A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | WO2009046346A8 Stem cell therapy for weight loss |
| 06/04/2009 | WO2009045308A3 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 06/04/2009 | WO2006135436A3 Inhibition of gene expression and therapeutic uses thereof |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144839 Methods and compositions for detecting and treating retinal diseases |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143322 Cell transfecting formulations of small interfering rna related compositions and methods of making and use |